Three Sci-tech innovation IPOs in China approved

(MENAFN)

The initial public offering (IPO) of three companies on the science and technology innovation board has been approved by the securities regulator in China.

Shanghai Taitan Scientific Co., Ltd., Frontier Biotechnologies Inc. and Shenzhen Consys Science & Technology Co., Ltd. are both going to be listed on the Shanghai Stock Exchange’s sci-tech innovation board, which is also called the STAR market the China Securities Regulatory Commission said.

The companies and their underwriters are going to confirm the IPO dates and released their prospectuses after discussions with the stock exchange.

The STAR market that was made in June of the earlier year to support firms in the high-tech and strategic emerging sectors, makes listing criteria easier but it has higher requirements for information disclosure.

MENAFN2109202000450000ID1100830363


Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy,

Read More
Read More

Digging into the next wave of tech IPOs

After taking five consecutive business days off from my work laptop — and to shout at my personal laptop while losing games on Dominion online — I am back. I missed you. And while The Exchange’s regular columns were off this week (Friday aside, which you can read here), there’s still a hell of a lot to talk about.

First, a new website. If you click here, you’ll be taken to a sortable list (spreadsheet? database?) of startups with Black founders. Dubbed The Black Founder List, it’s a great asset and tool.

For folks like myself with a research and reporting focus, the list’s sortability of companies founded by Black entrepreneurs by gender, stage and market focus is amazing. And, for investors, it should provide potential dealflow. Do you write lots of Series C checks? The Black Founder List has 23 Series B startups with Black founders. Or if you

Read More
Read More

The 3 Best-Performing IPOs of 2020

Investing in IPOs is inherently risky, as many companies nowadays go public at exuberant valuations in order to raise as much money as quickly as possible. But if excited investors aren’t careful, buying companies that recently IPO’d could quickly turn into speculation — buying shares at an artificially inflated price based on the sole belief that someone else will buy them at an even higher price. 

During market crashes, expensive stocks with long winning streaks tend to fall the hardest as investors finally come to the realization that they overpaid for their shiny new assets. As we come to grips with the possibility of a second coronavirus market crash, let’s look at three of the best performing IPOs of the year so far, and ask whether or not now is the right time to scoop up their shares.

Doctor fills out prescription form, full pill bottle besides him

Image source: Getty Images

1. CureVac

Since its IPO on Aug. 14,

Read More
Read More

Forget Hot IPOs, Buy These Top Tech Stocks Instead

With the tech industry flying high amid the pandemic, the pace of new IPOs and interest in them has been fast and furious. Recent debuts have set a new bar for ludicrous valuation. Snowflake (NYSE:SNOW), for example, is trading for well over 100 times trailing-12-month revenue — a price tag that assumes flawless execution of its growth strategy in the cloud industry, and then some.

There are more timely purchases out there, though. Three Fool.com contributors think Veeva Systems (NYSE:VEEV), Spotify (NYSE:SPOT), and Alphabet (NASDAQ:GOOGL)(NASDAQ:GOOG) are worth some of your money right now.

Honeycomb shaped cells with illustrations of tech devices in them.

Image source: Getty Images.

A consistent home-run hitter in life sciences

Nicholas Rossolillo (Veeva Systems): First off, I need to acknowledge my pick is no value. On the contrary, cloud computing technologist Veeva Systems trades for 31 times trailing-12-month revenue and 28 times expected fiscal year 2021 (the 12 months ended Jan. 31,

Read More
Read More

With Asana, JFrog, Palantir, Snowflake, Sumo and Unity, we’re in peak season for tech IPOs

Editor’s note: Get this free weekly recap of TechCrunch news that any startup can use by email every Saturday morning (7 a.m. PT). Subscribe here.

Pandemic numbers are looking better, it’s still a couple months before U.S. elections and a growing line of tech companies have already ventured out into public markets successfully this summer. Hard to imagine conditions beating the present any time soon, whether you’re traditionally banked, going with a direct listing or getting inside a SPAC vehicle.

We covered the frenzy this week with an eye toward what other startups can learn about the way these companies have arrived at this point. Here are the headlines for each, from Asana to Unity.

But first, consider this special episode of our Equity podcast from Wednesday, where the team reviews the news. And for a faster(ish) read, Extra Crunch subscribers should also check out Alex Wilhelm’s “super-long roundup” of

Read More
Read More

China green lights 4 sci-tech novelty IPOs

(MENAFN) China’s securities controller has accepted the listing for the initial public offerings (IPOs) of four corporations on the science and technology novelty plank.

The China Securities Regulatory Commission stated that Wuhan Keqian Biology Co., Ltd., Road Environment Technology Co., Ltd., Zhejiang Lante Optics Co., Ltd. and Chipsea Technologies (Shenzhen) Corp., Ltd., will be scheduled on the Shanghai Stock Exchange’s sci-tech novelty board, frequently known as the STAR marketplace.

The corporations and their underwriters will corroborate the IPO dates and issue their brochures subsequent to deliberations with the stock exchange.

The STAR marketplace, installed in June last year and intended to hold up corporations in the high-tech and strategic rising sectors, eases listing criteria but adopts higher obligations for information revelation.

MENAFN3008202000450000ID1100717413


Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos,

Read More
Read More